[Antidiabetogenic action of Pro-Gly-Arg and Pro-Gly-Pro-Arg peptides after their intranasal chronic administration to animals]. 2009

A M Ul'ianov, and L A Liapina, and T Iu Obergan, and T A Shubina, and V E Pastorova, and L A Andreeva, and N F Miasoedov, and I P Ashmarin

It was shown that chronic (over 7 days) intranasal injection of the Pro-Gly-Arg tripeptide to rats in the dose 1 mg/kg before the injection of a diabetogenic dose of alloxan, promotes effective defense against development of insulin dependent diabetes mellitus. At the same time, the tetra-peptide Pro-Gly-Pro-Arg did not show a hypoglycemic affect during diabetes mellitus provocation. Administration of Pro-Gly-Arg and Pro-Gly-Pro-Arg peptides also activates anticoagulation potential.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008297 Male Males
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D000281 Administration, Intranasal Delivery of medications through the nasal mucosa. Drug Administration, Intranasal,Administration, Intranasal Drug,Administration, Nasal,Intranasal Administration,Intranasal Drug Administration,Administrations, Intranasal,Administrations, Intranasal Drug,Administrations, Nasal,Drug Administrations, Intranasal,Intranasal Administrations,Intranasal Drug Administrations,Nasal Administration,Nasal Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

A M Ul'ianov, and L A Liapina, and T Iu Obergan, and T A Shubina, and V E Pastorova, and L A Andreeva, and N F Miasoedov, and I P Ashmarin
October 2007, Bulletin of experimental biology and medicine,
A M Ul'ianov, and L A Liapina, and T Iu Obergan, and T A Shubina, and V E Pastorova, and L A Andreeva, and N F Miasoedov, and I P Ashmarin
December 2017, Bulletin of experimental biology and medicine,
A M Ul'ianov, and L A Liapina, and T Iu Obergan, and T A Shubina, and V E Pastorova, and L A Andreeva, and N F Miasoedov, and I P Ashmarin
November 1997, The Journal of biological chemistry,
A M Ul'ianov, and L A Liapina, and T Iu Obergan, and T A Shubina, and V E Pastorova, and L A Andreeva, and N F Miasoedov, and I P Ashmarin
January 2011, Biopolymers,
A M Ul'ianov, and L A Liapina, and T Iu Obergan, and T A Shubina, and V E Pastorova, and L A Andreeva, and N F Miasoedov, and I P Ashmarin
July 1984, Proceedings of the National Academy of Sciences of the United States of America,
A M Ul'ianov, and L A Liapina, and T Iu Obergan, and T A Shubina, and V E Pastorova, and L A Andreeva, and N F Miasoedov, and I P Ashmarin
June 1995, Thrombosis research,
A M Ul'ianov, and L A Liapina, and T Iu Obergan, and T A Shubina, and V E Pastorova, and L A Andreeva, and N F Miasoedov, and I P Ashmarin
January 2011, Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections,
A M Ul'ianov, and L A Liapina, and T Iu Obergan, and T A Shubina, and V E Pastorova, and L A Andreeva, and N F Miasoedov, and I P Ashmarin
August 2008, Journal of peptide science : an official publication of the European Peptide Society,
A M Ul'ianov, and L A Liapina, and T Iu Obergan, and T A Shubina, and V E Pastorova, and L A Andreeva, and N F Miasoedov, and I P Ashmarin
July 2003, American journal of physiology. Heart and circulatory physiology,
A M Ul'ianov, and L A Liapina, and T Iu Obergan, and T A Shubina, and V E Pastorova, and L A Andreeva, and N F Miasoedov, and I P Ashmarin
June 2000, The Biochemical journal,
Copied contents to your clipboard!